SalaryGuide
AboutPricingBlogFor Employers
CompaniesBeiGene
BeiGene logo

BeiGene

Brand

  • Overview
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links
  • Insights
  • Jobs

Loading company data...

Loading jobs...

Company overview

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
Founded in 2010
Cambridge, Massachusetts, USA
2.4K employees (105 in marketing)
beonemedicines.com

Salaries

Typical salary range

$224,400 – $294,400

/ yr

Help build salary transparency at BeiGene

Share your compensation anonymously to see full data.

Contribute

People

Founders and leadership

Tiantian Xie
Tiantian Xie
WPS lead of China R&D, co-Founder Assistant
At the company for 14 years 1 month

Marketing leadership

Jason French
Jason French
Sr Director Regional Marketing, US
At the company for 4 years 7 months
Greg Koyama
Greg Koyama
Director of Regional Marketing
At the company for 4 years 2 months
Elly Zhu
Elly Zhu
Associate Director, Talent Acquisition, JAPAC
At the company for 6 years 6 months
Karen Bartosh, PA-C, M-PAS, MS
Karen Bartosh, PA-C, M-PAS, MS
Associate Director, Regional Marketing
At the company for 4 years 3 months

Hiring contacts

Elly Zhu
Elly Zhu
Associate Director, Talent Acquisition, JAPAC
At the company for 6 years 6 months
Brian Choi, SHRM-CP
Brian Choi, SHRM-CP
Associate Talent Acquisition Manager
At the company for 3 years 2 months

Headcount trend

Company growth over the last 12 months

Funding

Total funding

$6.8B

Last raise

$2.1B

Post IPO Equity, 6 years ago

Funding history

Jul 2020

Post IPO Equity BeiGene · $2.1B

Oct 2019

Post IPO Equity BeiGene · $2.7B

Aug 2018

Post IPO Secondary BeiGene · $903M

Jan 2018

Post IPO Equity BeiGene · $750M

Nov 2016

Post IPO Equity BeiGene · $185M

Audience

Monthly website visitors
39.3K
Month over month-3.1%
Quarter over quarter+2214%
Top sourceReferral (41.7%)
Ad budget per month$37.5K
Average search rank53
Traffic source mix
Referral
41.7%
Search
31.8%

News

BeiGene stock falls on Trump EO concerns, RBC sees buying opportunity
Sep 11, 2025 • Investing.com
BeiGene beats revenue expectations but misses on earnings in second quarter
Aug 6, 2025 • Investing.com
Lymphoma Treatment Market to Surpass USD 14.66 Billion by 2032, Fueled by Immunotherapy Advancements and Emerging Market Expansion - SNS Insider
Jul 18, 2025 • SNS Insider pvt ltd

Links

beonemedicines.comLinkedInCrunchbaseX (Twitter)

Loading insights...

Headcount -9.9% year over year

May 2015

Series B BeiGene · $97M

Direct
20.2%
Social
5.2%
Paid referral
1%

LinkedIn followers

Follower count and growth

Total followers

206.7K

12-mo growth

—

Monthly growth

+0.7%

Open positions23 open marketing positions

BeiGene logo

Marketing Director, Haematology, UK and Ireland

BeiGene

UK (Remote)

£105K/yr - £131K/yrIn-houseFull-timeSenior level10+ years exp.
5 days ago
BeiGene logo

Senior Manager, Marketing – Brukinsa

BeiGene

USA (Remote)

$149K/yr - $194K/yrIn-houseFull-timeSenior level7+ years exp.
11 days ago
BeiGene logo

Associate Director, Patient Services Promotions (Patient Marketing Experience Required)

BeiGene

USA (Remote)

$145K/yr - $195K/yrIn-houseFull-timeManager8+ years exp.
3 weeks ago
BeiGene logo

Associate Director, Market Access Strategic Marketing

BeiGene

USA (Hybrid)

$153K/yr - $203K/yrIn-houseFull-timeSenior level8+ years exp.
5 weeks ago
BeiGene logo

Director IT Commercial Systems and CRM Operations – Global Commercial Technology

BeiGene

San Carlos, CA (On-site)

$173K/yr - $233K/yrIn-houseFull-time
5 weeks ago
BeiGene logo

Senior Global Brand Protection Analyst

BeiGene

USA (Remote)

$98K/yr - $133K/yrIn-houseFull-time
2 months ago
View all 23 jobs

BeiGene insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded
2010
Headquarters
Cambridge, Massachusetts
Employees
myself only
9.9% decline last 12mo
Marketing team
105
4% of company
51 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result
Medium risk
Late-stage · Shrinking 9.9% last 12 months · More mature · Last funding 3+ years ago
Trend
2023-03-27 -> 2025-12-29
Headcount (12 months)
-9.9%
Last funding round
69 months ago
Negative news (120 days)
0
Risk score4/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors
39.3K
Month over month-3.1%
Quarter over quarter+2214%
Top sourceReferral (41.7%)
Traffic source mix
Referral
41.7%
Search
31.8%
Direct

Competitors and search

Shows competitors and key search metrics in one view.

Main result
0 competitor sites
Search traffic: 2.3K organic clicks / 6.6K paid clicks
Organic competitors
0
Paid competitors
0
Keyword change
+184
Ad budget per month
$37.5K
Average search rank
53

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

206.7K

12-mo growth

—

Monthly growth

+0.7%

Marketing team size

Shows saved marketing team size.

105
4% of the company • 51 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team
Based on saved marketing team size: 105.

Funding

Shows saved funding data.

Total funding
$6.8B
Last raise
Post IPO Equity
6 years ago
Funding details
Amount raised
$6.8B
Last round
Post IPO Equity
Last fundraise
6 years ago

News

Shows saved company news.

BeiGene stock falls on Trump EO concerns, RBC sees buying opportunity
Sep 11, 2025 • Investing.com
BeiGene beats revenue expectations but misses on earnings in second quarter
Aug 6, 2025 • Investing.com
Lymphoma Treatment Market to Surpass USD 14.66 Billion by 2032, Fueled by Immunotherapy Advancements and Emerging Market Expansion - SNS Insider
Jul 18, 2025 • SNS Insider pvt ltd
20.2%
Social
5.2%
Paid referral
1%